NCT06494423 Employment Support After Hematopoietic Stem Cell Transplantation
| NCT ID | NCT06494423 |
| Status | Recruiting |
| Phase | — |
| Sponsor | MGH Institute of Health Professions |
| Condition | Hematopoietic Stem Cell Transplantation |
| Study Type | INTERVENTIONAL |
| Enrollment | 35 participants |
| Start Date | 2024-07-31 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 35 participants in total. It began in 2024-07-31 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a feasibility study of a Work Support (WorkS) intervention designed to ameliorate employment challenges for people preparing to return to work after allogeneic stem cell transplantation. The aim of this study is to evaluate "proof of concept" by: 1. examining the feasibility and acceptability of the WorkS intervention and the study procedures, and 2. exploring the preliminary effects of WorkS for improving patient-reported return-to-work self-efficacy, work status, quality of life, and financial toxicity.
Eligibility Criteria
Inclusion Criteria: * Received an allogeneic HSCT within the past six months to treat a hematological malignancy. * Screen positive for work-related concerns (i.e., responds "yes" to the question, "Are you concerned about your ability to return to work in the coming six months?") Exclusion Criteria: * Patients with acute psychiatric or cognitive conditions which the treating clinician believes prohibits informed consent or compliance with the study procedures * We will not enroll the following special populations: adults unable to consent, individuals not yet adults, pregnant women, and prisoners.
Contact & Investigator
Kathleen Lyons, ScD, OTR/L
PRINCIPAL INVESTIGATOR
MGH Institute of Health Professions
Frequently Asked Questions
Who can join the NCT06494423 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Hematopoietic Stem Cell Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06494423 currently recruiting?
Yes, NCT06494423 is actively recruiting participants. Contact the research team at klyons2@mghihp.edu for enrollment information.
Where is the NCT06494423 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT06494423 clinical trial?
NCT06494423 is sponsored by MGH Institute of Health Professions. The principal investigator is Kathleen Lyons, ScD, OTR/L at MGH Institute of Health Professions. The trial plans to enroll 35 participants.